Mass M J, Abu-Shakra A, Roop B C, Nelson G, Galati A J, Stoner G D, Nesnow S, Ross J A
Biochemistry and Pathobiology Branch (MD-68), National Health and Environmental Effects Research Laboratory, US Environmental Protection Agency, Research Triangle Park, NC 27711, USA.
Carcinogenesis. 1996 Aug;17(8):1701-4. doi: 10.1093/carcin/17.8.1701.
The polycyclic aromatic hydrocarbon benzo[b]fluoranthene (B[b]F) is a pervasive constituent of environmental combustion products. We sought to examine the lung tumorigenic activity of B[b]F in strain A/J mice, to study the relationship between formation and decay of B[b]F-DNA adducts and to examine mutations in the Ki-ras proto-oncogene in DNA from B[b]F-induced tumors. Mice were given i.p. injections of 0, 10, 50, 100 or 200 mg/kg body wt and lung adenomas were scored after 8 months. B[b]F induced significant numbers of mouse lung adenomas in a dose-related fashion, with the highest dose (200 mg/kg) yielding 6.95 adenomas/ mouse, with 100% of the mice exhibiting an adenoma. In mice given tricaprylin, the vehicle control, there were 0.60 adenomas/mouse, with 55% of the mice exhibiting an adenoma. Based on dose, B[b]F was less active than benzo[a]pyrene. DNA adducts were analyzed qualitatively and quantitatively by 32P-post-labeling in lungs of strain A/J mice 1, 3, 5, 7, 14 and 21 days after i.p. injection. Maximal levels of adduction occurred 5 days after treatment with the 200 mg/kg dose group, producing 1230 amol B[b]F-DNA adducts/microgram DNA. The major B[b]F-DNA adduct was identified by co-chromatography as trans-9, 10-dihydroxy-anti-11, 12-epoxy-5-hydroxy-9, 10, 11, 12-tetra-hydro-B[b]F-deoxyguanosine. Approximately 86% of the tumors had a mutation in codon 12 of the Ki-ras oncogene, as determined by direct DNA sequencing of PCR-amplified exon 1 and single-stranded conformation polymorphism analysis. Analysis of the Ki-ras mutation spectrum in 25 of 29 B[b]F-induced tumors revealed the predominant mutation to be a G-->T transversion in the first or second base of codon 12, congruous with the DNA adduct data. Our data are consistent with previous reports in mouse skin implicating a phenolic diol epoxide as the proximate carcinogenic form of B[b]F that binds to guanine.
多环芳烃苯并[b]荧蒽(B[b]F)是环境燃烧产物中普遍存在的成分。我们试图研究B[b]F在A/J品系小鼠中的肺致瘤活性,探讨B[b]F-DNA加合物形成与衰变之间的关系,并检测B[b]F诱导肿瘤的DNA中Ki-ras原癌基因的突变情况。给小鼠腹腔注射0、10、50、100或200mg/kg体重的B[b]F,8个月后对肺腺瘤进行计数。B[b]F以剂量相关的方式诱导产生大量小鼠肺腺瘤,最高剂量(200mg/kg)时每只小鼠产生6.95个腺瘤,100%的小鼠出现腺瘤。在给予三辛酸甘油酯(赋形剂对照)的小鼠中,每只小鼠有0.60个腺瘤,55%的小鼠出现腺瘤。基于剂量,B[b]F的活性低于苯并[a]芘。在腹腔注射后1、3、5、7、14和21天,通过32P后标记法对A/J品系小鼠肺中的DNA加合物进行定性和定量分析。200mg/kg剂量组在处理后5天出现最大加合水平,每微克DNA产生1230个amol B[b]F-DNA加合物。通过共色谱法鉴定出主要的B[b]F-DNA加合物为反式-9,10-二羟基-反式-11,12-环氧-5-羟基-9,十氢-B[b]F-脱氧鸟苷。通过对PCR扩增的外显子-1进行直接DNA测序和单链构象多态性分析,确定约86%的肿瘤在Ki-ras癌基因的第12密码子处发生突变。对29个B[b]F诱导肿瘤中的25个进行Ki-ras突变谱分析,结果显示主要突变是第12密码子第一个或第二个碱基处的G→T颠换,这与DNA加合物数据一致。我们的数据与之前在小鼠皮肤中的报道一致,表明酚类二醇环氧化物是B[b]F与鸟嘌呤结合的直接致癌形式。